vTv Therapeutics Inc. (VTVT)
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
VTVT Insider Trading Activity
VTVT Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $83,812 | 2 | 100 |
Sells | $0 | 0 | 0 |
Related Transactions
| SEKHRI PAUL J | Pres, CEO and Exec Chairperson | 2 | $83,812 | 0 | $0 | $83,812 |
About vTv Therapeutics Inc.
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases and psoriasis. It is also involved in the clinical development of other programs, including TTP273, an oral small molecule …
Insider Activity of vTv Therapeutics Inc.
Over the last 12 months, insiders at vTv Therapeutics Inc. have bought $83,812 and sold $0 worth of vTv Therapeutics Inc. stock.
On average, over the past 5 years, insiders at vTv Therapeutics Inc. have bought $1.45M and sold $100,050 worth of stock each year.
Highest buying activity among insiders over the last 12 months: SEKHRI PAUL J (Pres, CEO and Exec Chairperson) — $83,812.
The last purchase of 1,844 shares for transaction amount of $31,269 was made by SEKHRI PAUL J (Pres, CEO and Exec Chairperson) on 2024‑11‑18.
List of Insider Buy and Sell Transactions, vTv Therapeutics Inc.
| 2024-11-18 | SEKHRI PAUL J | Pres, CEO and Exec Chairperson | 1,844 0.058% | $16.96 | $31,269 | -8.58% | ||
| 2024-11-15 | SEKHRI PAUL J | Pres, CEO and Exec Chairperson | 3,156 0.1377% | $16.65 | $52,543 | -11.15% | ||
| 2022-11-29 | FRY JOHN A | director | 40,461 0.0852% | $0.83 | $33,773 | -12.01% | ||
| 2022-11-28 | FRY JOHN A | director | 20,539 0.0431% | $0.83 | $16,969 | -11.38% | ||
| 2021-12-20 | Sale | PERELMAN RONALD O | director | 87,000 0.154% | $1.15 | $100,050 | -26.54% | |
| 2021-02-26 | Nelson Rich S. | director | 60,000 0.1142% | $2.86 | $171,600 | -31.58% | ||
| 2021-02-26 | KOZLOV HERSH | director | 10,000 0.0182% | $2.74 | $27,400 | -31.58% | ||
| 2020-12-17 | PERELMAN RONALD O | director | 625,000 0.9225% | $1.60 | $1M | -2.36% | ||
| 2020-12-10 | PERELMAN RONALD O | director | 625,000 0.893% | $1.60 | $1M | -4.79% | ||
| 2020-11-24 | PERELMAN RONALD O | director | 625,000 1.0514% | $1.60 | $1M | +13.44% | ||
| 2020-05-15 | KOZLOV HERSH | director | 10,000 0.022% | $3.00 | $30,000 | -22.48% | ||
| 2020-05-12 | PERELMAN RONALD O | director | 625,000 0.8555% | $1.60 | $1M | -8.98% | ||
| 2020-02-25 | PERELMAN RONALD O | director | 1.25M 1.438% | $1.60 | $2M | -33.44% | ||
| 2020-01-28 | PERELMAN RONALD O | director | 1.25M 2.1109% | $1.60 | $2M | -2.29% | ||
| 2020-01-07 | PERELMAN RONALD O | director | 1.25M 2.5998% | $1.60 | $2M | +20.34% | ||
| 2019-12-18 | PERELMAN RONALD O | director | 1.37M 4.3437% | $1.46 | $2M | +40.13% | ||
| 2019-11-26 | PERELMAN RONALD O | director | 1.37M 4.4914% | $1.46 | $2M | +42.86% | ||
| 2019-11-12 | PERELMAN RONALD O | director | 1.37M 4.3437% | $1.46 | $2M | +38.16% | ||
| 2019-10-24 | PERELMAN RONALD O | director | 1.37M 4.2053% | $1.46 | $2M | +33.76% | ||
| 2019-09-26 | PERELMAN RONALD O | director | 1.37M 4.3232% | $1.46 | $2M | +45.83% |
Insider Historical Profitability
| SEKHRI PAUL J | Pres, CEO and Exec Chairperson | 5000 0.1914% | $104,950.00 | 2 | 0 | |
| PERELMAN RONALD O | director | 36519212 1397.993% | $766.54M | 61 | 1 | +17.2% |
| SAVAS PAUL G | director | 91781 3.5135% | $1.93M | 16 | 0 | +66.67% |
| FRY JOHN A | director | 61000 2.3351% | $1.28M | 2 | 0 | <0.0001% |
| Nelson Rich S. | director | 50000 1.9141% | $1.05M | 1 | 0 | <0.0001% |
Historical Insider Profitability vs. Competitors
$81,638,324 | 48 | 7.58% | $59.66M | |
vTv Therapeutics Inc. (VTVT) | $77,062,892 | 41 | 13.96% | $54.83M |
$6,787,959 | 35 | 49.84% | $61.13M | |
$459,011,221 | 33 | 33.04% | $58.46M | |
$2,239,226 | 28 | 3.41% | $58.08M |
VTVT Institutional Investors: Active Positions
| Increased Positions | 6 | +33.33% | 10,192 | +1.88% |
| Decreased Positions | 3 | -16.67% | 467 | -0.09% |
| New Positions | <1 | New | 1,803 | New |
| Sold Out Positions | 3 | Sold Out | 467 | Sold Out |
| Total Postitions | 21 | +16.67% | 552,049 | +1.79% |
VTVT Ownership Change vs Market
Institutional Investor Ownership
| Samsara Biocapital, Llc | $3,071.00 | 6.89% | 206,784 | 0 | 0% | 2024-12-31 |
| Fmr Llc | $2,646.00 | 5.94% | 178,200 | 0 | 0% | 2024-12-31 |
| Baker Bros. Advisors Lp | $1,445.00 | 3.24% | 97,314 | 0 | 0% | 2024-12-31 |
| Vanguard Group Inc | $617.00 | 1.39% | 41,558 | 0 | 0% | 2024-12-31 |
| Geode Capital Management, Llc | $173.00 | 0.39% | 11,634 | +1,327 | +12.88% | 2024-12-31 |
| Ubs Group Ag | $112.00 | 0.25% | 7,512 | +6,646 | +767.44% | 2024-12-31 |
| Blackrock, Inc. | $71.00 | 0.16% | 4,773 | +23 | +0.48% | 2024-12-31 |
| Jpmorgan Chase & Co | $27.00 | 0.06% | 1,803 | +1,803 | New | 2024-12-31 |
| Morgan Stanley | $17.00 | 0.04% | 1,146 | +306 | +36.43% | 2024-12-31 |
| Planning Capital Management Corp | $9.00 | 0.02% | 625 | 0 | 0% | 2024-09-30 |